This has been the worst April performance of the overall market since 1970.  So I don't think you can blame RVX entirely for what has been going on over past few weeks.  Yes, I recognize that a SP of 0.50 is also nothing to brag about when staring at a price less than $C0.40.  However RVX is also not immune to getting swept up in negative market sentiment overall.  Given the results RVX has achieved with apabetalone over the past few years, and the potential of what it could achieve with a successful BoM2 trial then you have to think that you'll never get this stock any cheaper than what it is now.  The relative risk associated with lowering one's average cost at this price vs. what the stock could easily climb to with any sort of positive news on the above trials and the financing thereof makes it super tempting, even though it does perhaps seem like it's throwing good money after bad.  But, 12 months from now I could also be kicking myself for not having acted when I shoul have.  Hmmmmm.....what to do??